| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |